Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | HCID 44220648 | HCID 44220648 | — |
| Reactant | Methyl 2-chlorobenzo[d]oxazole-4-carboxylate | HCID 56924368 | — |
| Solvent | 1,2-Dimethoxyethane | HCID 8071 | — |
| Product | HCID 66873650 | HCID 66873650 | 39% |
Reaction Steps
To (S)-4-tert-butyloxycarbonyl-2-tert-butylpiperazine (640 mg, 2.6 0 mmol) in DME (10 mL) at room temperature, was added NaH (60% suspension in mineral oil, 115 mg, 3.50 mmol) and the mixture was stirred for 45 min. Methyl 2-chlorobenzoxazole-4-carboxylate (780 mg, 3.69 mmol) was added to the reaction mixture and the reaction was stirred at room temperature for 3d and at 55° C. for 24 h. The reaction mixture was quenched with CH3OH (10 mL), silica gel (15 mL) was added, and solvent removed under reduced pressure. The residue was purified by column chromatography (silica gel, 33% EtOAc in hexanes) to afford (S)-methyl 2-(4-tert-butyloxycarbonyl-2-tert-butyl-piperazin-1-yl)benzoxazole-4-carboxylate (0.42 g, 39%) as a yellow solid. 1H NMR and MS consistent.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07863271B2 |
|---|
| Source dataset | uspto-grants-2011_01 |
|---|
| ORD ID | ord-0165dcb8eade4dde908b330b17ed6ce2 |
|---|
| Source note | uspto-grants-2011_01 |
|---|